GLP-1 Drugs May Cut Risk of Pesky GI Condition

(MedPage Today) — Patients with type 2 diabetes who were treated with GLP-1 receptor agonists were less likely to develop peptic ulcer disease (PUD), a nationwide study found.
In an analysis of more than 65,000 patients, GLP-1 users had 44% lower…